Relation between cardiac troponin I and mortality in acute decompensated heart failure

American Heart Journal

Volumn 153, Issue 4, 2007, Pages 462-470

  You, John J ^a,b,d   Austin, Peter C ^a,c   Alter, David A ^a,b,c,e   Ko, Dennis T ^a,b,d,e   Tu, Jack V ^a,b,c,d  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I;

ACUTE HEART FAILURE; AGED; CANADA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HAZARD RATIO; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION BASED CASE CONTROL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS;

ACUTE DISEASE; AGED; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; TROPONIN I;

EID: 33947328285     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.01.027     Document Type: Review

References (48)

1. American Heart Association. Heart Disease and Stroke Statistics-2005 Update. Dallas, Texas, American Heart Association.
2. Jessup M., and Brozena S. Heart failure. N Engl J Med 348 (2003) 2007-2018
3. Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337 (1997) 1360-1369
4. Heidenreich P.A., Alloggiamento T., Melsop K., et al. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 38 (2001) 478-485
5. Newby L.K., Goldmann B.U., and Ohman E.M. Troponin: an important prognostic marker and risk-stratification tool in non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 41 (2003) 31S-36S
6. Jaffe A.S., Ravkilde J., Roberts R., et al. It's time for a change to a troponin standard. Circulation 102 (2000) 1216-1220
7. Setsuta K, Seino Y, Takahashi N et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 1999; 84:608-11, A9
8. La Vecchia L., Mezzena G., Zanolla L., et al. Cardiac troponin I as diagnostic and prognostic marker in severe heart failure. J Heart Lung Transplant 19 (2000) 644-652
9. Sato Y., Yamada T., Taniguchi R., et al. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 103 (2001) 369-374
10. Setsuta K., Seino Y., Ogawa T., et al. Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure. Am J Med 113 (2002) 717-722
11. Perna E.R., Macin S.M., Parras J.I., et al. Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema. Am Heart J 143 (2002) 814-820
12. Ishii J., Nomura M., Nakamura Y., et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 89 (2002) 691-695
13. Ishii J., Cui W., Kitagawa F., et al. Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure. Clin Chem 49 (2003) 2020-2026
14. Perna E.R., Macin S.M., Cimbaro Canella J.P., et al. High levels of troponin T are associated with ventricular remodeling and adverse in-hospital outcome in heart failure. Med Sci Monit 10 (2004) CR90-CR95
15. Taniguchi R., Sato Y., Yamada T., et al. Combined measurements of cardiac troponin T and N-terminal pro-brain natriuretic peptide in patients with heart failure. Circ J 68 (2004) 1160-1164
16. Perna E.R., Macin S.M., Cimbaro Canella J.P., et al. Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure. Int J Cardiol 99 (2005) 253-261
17. Nieminen M.S., Bohm M., Cowie M.R., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 384-416
18. Lee D.S., Austin P.C., Rouleau J.L., et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290 (2003) 2581-2587
19. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Services, U.S. Department of Health and Human Services, 1988.
20. Lee D.S., Donovan L., Austin P.C., et al. Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care 43 (2005) 182-188
21. Roger V.L., Weston S.A., Redfield M.M., et al. Trends in heart failure incidence and survival in a community-based population. JAMA 292 (2004) 344-350
22. McKee P.A., Castelli W.P., McNamara P.M., et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med 285 (1971) 1441-1446
23. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-266
24. Freda B.J., Tang W.H., Van Lente F., et al. Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol 40 (2002) 2065-2071
25. Khan I.A., Wattanasuwan N., Mehta N.J., et al. Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: a two-year outcome analysis. J Am Coll Cardiol 38 (2001) 991-998
26. Apple F.S., Murakami M.M., Pearce L.A., et al. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 106 (2002) 2941-2945
27. Collinson P.O., Stubbs P.J., and Morgan S.H. Cardiac troponin-I accurately predicts myocardial injury in renal failure. Nephrol Dial Transplant 14 (1999) 1030-1031
28. Apple F.S., Wu A.H., and Jaffe A.S. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 144 (2002) 981-986
29. Alpert J.S., Thygesen K., Antman E., et al. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
30. Lee D.S., Tran C., Flintoft V., et al. CCORT/CCS quality indicators for congestive heart failure care. Can J Cardiol 19 (2003) 357-364
31. Fonarow G.C., Adams Jr. K.F., Abraham W.T., et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293 (2005) 572-580
32. Polanczyk C.A., Rohde L.E., Philbin E.A., et al. A new case mix adjustment index for hospital mortality among patients with congestive heart failure. Med Care 36 (1998) 1489-1499
33. Myers R.H. Classical and modern regression with applications. 2nd ed. (1990), Duxberry Press, Belmont, CA
34. La Vecchia L., Mezzena G., Ometto R., et al. Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin. Am J Cardiol 80 (1997) 88-90
35. Healey J.S., Davies R.F., Smith S.J., et al. Prognostic use of cardiac troponin T and troponin I in patients with heart failure. Can J Cardiol 19 (2003) 383-386
36. Horwich T.B., Patel J., MacLellan W.R., et al. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 108 (2003) 833-838
37. Hudson M.P., O'Connor C.M., Gattis W.A., et al. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. Am Heart J 147 (2004) 546-552
38. Stanton E.B., Hansen M.S., Sole M.J., et al. Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure. Can J Cardiol 21 (2005) 39-43
39. Logeart D., Beyne P., Cusson C., et al. Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain. Am Heart J 141 (2001) 247-253
40. Jeremias A., and Gibson C.M. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 142 (2005) 786-791
41. Mann D.L. Mechanisms and models in heart failure: a combinatorial approach. Circulation 100 (1999) 999-1008
42. Perna E.R., Macin S.M., Canella J.P., et al. Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification. Circulation 110 (2004) 2376-2382
43. Sato Y., Kita T., Takatsu Y., et al. Biochemical markers of myocyte injury in heart failure. Heart 90 (2004) 1110-1113
44. Fonarow G.C., and Horwich T.B. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure. Rev Cardiovasc Med 4 Suppl 4 (2003) S20-S28
45. Doust J.A., Glasziou P.P., Pietrzak E., et al. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 164 (2004) 1978-1984
46. Doust J.A., Pietrzak E., Dobson A., et al. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330 (2005) 625
47. Moe G. N-terminal proB-type natriuretic peptide improves the management of patients with suspected acute decompensated heart failure: primary results of the Canadian multicenter IMPROVE-CHF study. Chicago, IL: American Heart Association 2006 Scientific Sessions (2006) [abstract]
48. Apple F.S., Panteghini M., Ravkilde J., et al. Quality specifications for B-type natriuretic peptide assays. Clin Chem 51 (2005) 486-493